Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
ATAI Investor Day Presentation Deck slide image

ATAI Investor Day Presentation Deck

Objective of RL - 007 Phase 2a study Extend prior clinical data to CIAS patients Safety and tolerability Confirm CNS activity via EEG in schizophrenia population Define dose-response in pro-cognitive dose range (go lower than previous studies) Explore acute cognitive signals in CIAS patients ā— ā— atai LIFE SCIENCES | 33
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube